NGNora Granana

Nora Granana

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nora Granana has a total of 55 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The Brief Observation of Symptoms of Autism: Validation study in a Latin American sample

    by Nora Granana, Francisco Astorino, Alba Richaudeau, Lucas Costa, Elena Fernandez de Carrera, Valeria Nanclares, Kristin Sohl

    Autism spectrum disorder presents as a multifaceted condition characterized by pronounced impairments in social communication and behavioral patterns. Diagnosis hinges upon the expertise of clinicians, comprehensive developmental history, and observation of specific behavioral markers. However, in low-income countries, access to screening tools and standardized diagnostic tests for autism spectrum disorder remains profoundly limited. Moreover, the COVID-19 pandemic has exacerbated these challenges, rendering diagnostic protocols impractical. In response to these barriers, the Brief Observation of Symptoms of Autism instrument was developed to facilitate assessments via telehealth during the pandemic. This study aims to validate the use of the Brief Observation of Symptoms of Autism within two Latin American countries, Argentina, and Chile. A cohort of 313 spanning various age groups underwent examination. Psychometric properties of each Brief Observation of Symptoms of Autism module were scrutinized, including sensitivity and specificity against the recommended University of California at Los Angeles cutoffs. Receiver operating characteristic curve analysis yielded credible sensitivity and specificity scores for each module. Confirmatory factor analysis supported a favorable fit across modules, employing a 2-factor model distinguishing Social Affect and Restricted, Repetitive Behaviors. Preliminary findings affirm the validity of the Brief Observation of Symptoms of Autism as an effective diagnostic tool within the Latin American population. Furthermore, its potential extends beyond the pandemic, promising support in the future. Lay Autism spectrum disorder is a complex condition associated with significant impairments in social communication and behavioral functioning. Diagnosis is dependent on clinician expertise, gathering of developmental history, and observation of specific behaviors. The suggested protocols include tools rendered invalid during the pandemic, which created significant barriers for diagnostic assessments. Furthermore, there are additional barriers in low-income countries in access to screening tools and standardized diagnostic tests for autism spectrum disorders that were only exacerbated during COVID-19. The Brief Observation of Symptoms of Autism instrument was developed to improve access to diagnostic assessment via telehealth during this time. The current study sought to validate the use of the Brief Observation of Symptoms of Autism within two Latin American countries. A sample of 313 children and adults from Argentina and Chile were examined. Results showed valid sensitivity and specificity scores with good fit across modules using two factors (i.e. Social Affect and Restricted, Repetitive Behaviors). Preliminary results of the current study demonstrated that the Brief Observation of Symptoms of Autism is a valid instrument for Latin American population and shows promise to be used beyond the pandemic to ease the diagnostic process. This is a collaborative work with BRINCAR Parent Association, who defined the need in our country to run the validation of Brief Observation of Symptoms of Autism and gave us support as the stakeholders at Lancet Commission.


  • Open Access

    Impact on the nervous system of long COVID-19 infection in children

    by Nora Granana, Adriana Tarulla, Ismael Calandri, Analia De Carli, Belen Rivas, Jose Maria Festa, Susana Vacirca, María Lis, Iris Worff, Ricardo Allegri

    Background The coronavirus disease 2019 (COVID-19) pandemic has had a profound global impact, raising concerns about its long-term effects, particularly neurological complications. While studies have highlighted such complications in adults, there is a paucity of research focusing on children. Objective To examine the medium- to long-term neurological and cognitive symptoms in 18 year old children and below with positive versus negative COVID-19 antigens and to identify the probable risk factors to promote specific health actions. Methods An observational study was carried out to determine neurological symptoms in the medium and long terms after COVID 19. A random sample of 124 children, both symptomatic or asymptomatic, tested positive or negative for COVID-19 through swab tests. Results Neurological symptoms were assessed between 6 to 12 months and 2 years after the infection. Acute symptoms, including headache, anosmia, ageusia, and myalgia, were observed in more than 20% of the children, but they generally resolved within 6 to 12 months. Persistent functional difficulties, such as in studying, paying attention, and socializing, were reported in 3% of the cases. Behavioral symptoms at baseline were noted in 7.8% of children, but they were remitted in most cases, except for those with prior involvement. Conclusion These findings underscore the need for continued monitoring of children following COVID-19 infection and the importance of tailored health interventions.


  • Open Access

    Alteraciones cognitivas por quimioterapia en pacientes con cáncer de mama:

    by Bernardo Arce, Nora Grañana

    Antecedentes: Los pacientes con cáncer de mama pueden experimentar dificultades cognitivas por recibir quimioterapia. Dicha alteración es denominada Deterioro Cognitivo Quimioinducido, también es conocida como Chemobrain o Chemofog. Objetivo: Identificar el perfil cognitivo y las características de la evaluación neuropsicológica de esta población. Método: Se consultaron las bases de datos PubMed, SpringerLink y SciELO. Se seleccionaron artículos de 1994 hasta septiembre de 2021. Fueron utilizadas palabras claves relacionadas con el tema de estudio. Resultados: La quimioterapia puede producir un deterioro cognitivo entre el 15 y el 50% de las mujeres. Dicha alteración es de etiología múltiple y puede asociarse a factores biológicos y a cambios funcionales y/o estructurales del SNC. Se deben de considerar los factores sociodemográficos, clínicos y psicológicos como variables moduladoras. Se manifiesta principalmente en problemas de memoria, función ejecutiva, atención y velocidad de procesamiento. Esta alteración puede ser mensurada a través de los instrumentos de evaluación neuropsicológica disponibles. Discusión y conclusión: Se sugiere que la afectación cognitiva quimioinducida sea incorporada en el consentimiento informado. Se recomienda un mayor desarrollo de estudios longitudinales que se complementen con técnicas de neuroimágenes que permitan avanzar en el conocimiento de esta problemática. Se propone un protocolo de evaluación neuropsicológica, que incluye pruebas de screening, escalas clínicas, test neuropsicológicos específicos y de calidad de vida, según las recomendaciones del International Cognition and Cancer Task Force.


  • Open Access

    Infodemia en la Argentina preventivamente aislada. Un análisis de las Fake News sobre la pandemia de COVID-19 desmentidas por Confiar

    by Adilton Cícero Nogueira da Silva, Selediana De Souza Godinho, Analia Veronica Losada, Simon Bacon, Nora Granana, Carolina Gomez Jimenez

    Infodemia en la Argentina preventivamente aislada. Un análisis de las Fake News sobre la pandemia de COVID-19 desmentidas por Confiar


  • Open Access

    Representaciones Sociales sobre las Vacunas y la Vacunación frente al COVID 19

    by Valeria Fernanda Altamirano, Simon L. Bacon, Silvana Baró, Daniela Anahí Benítez, José Carlos Caravello, Natalia Lucia Filippa, Zulma Gabriela Gastaldo, Carolina Gómez Jiménez, Nora Estela Grañana, Kim L. Lavoie, et al.

    The representations are described as a specific style of knowledge, a specific way of deciphering reality, alluding to common sense thinking, being associated with a personal development that involves cognitive ordering and at the same time finds its beginning, its diffusion and change in the sociocultural context. In the health context given by the COVID 19 pandemic and showing how the greatest strategy used by the different governments of the world, vaccination takes relevance knowledge about representations about vaccination and vaccines. Within the framework of the multicenter study International COVID 19 Awareness and Responses Evaluation Study (ICARE) led by Montreal Behavioral Medicine Center, a survey was developed with a sample of 3330 Argentine adults, between 18 and 70 years old, composed mainly of university students and professionals. The objective of the research has been to know the representations about vaccines and vaccination. Among the results, the social representations of the participants that show great adherence to vaccination and vaccines stand out, with positive concepts in 8 out of 10 and a clear support for protection measures such as isolation and use of more veneer accompanying inoculation while living with COVID 19.


  • Open Access

    Eficacia de intervenciones en TEA: herramientas de valoración. Una Revisión sistemática.

    by Nora Grañana

    El autismo es un trastorno del neurodesarrollo con déficits en la comunicación social. El objetivo fue realizar una revisión sistemática de pruebas que permitan valorar resultados de psicoterapias con orientación cognitiva y conductual, en niños con autismo. Se evaluaron con el método PRISMA, sobre un total de 757 niños. Las escalas de conductas adaptativas Vineland, el análisis de videos, la Escala de Responsividad Social (SRS) y la prueba de Historias Extrañas, fueron efectivas. Esta revisión puede guiar la organización de una batería, para medir la efectividad clínica de intervenciones en comunicación social en niños con TEA.


  • ASQ-3: Validation of the Ages and Stages Questionnaire for the detection of neurodevelopmental disorders in Argentine children

    by Ana M. Romero Otalvaro, Nora Granana, Nadia Gaeto, Maria de los A. Torres, Maria N. Zamblera, Maria A. Vasconez, Claudia Misenta, Maria E. Rouvier, Jane Squires

    Introduction. The systematic assessment of child development in the first years of life is an essential component of pediatric health checkups. The Ages and Stages Questionnaire, third edition (ASQ-3) is the most validated scale, and has been recommended by the UNICEF to verify if children have a normal neurological development. It is a monitoring instrument to assess the main developmental areas, including communication, gross motor, fine motor, personal-social, and problem solving skills, and to compare the local population to the international development standards. Objective. To validate the ASQ-3 in a pediatric population group. Methods. Children aged 1-66 months were assessed at a public hospital by pediatricians, psychologists, and educational psychologists. The SSPS software package was used to determine population scales. Results. In 630 children, who had a homogeneous sex distribution, an 88% sensibility and a 94% specificity were determined, with a positive predictive value of 88% and a negative predictive value of 96%, compared to the National Screening Test (Prueba Nacional de Pesquisa, PRUNAPE) and the cut-off scores for each age group. Conclusion. The ASQ-3 established that 19.5% of children were at risk of experiencing neurodevelopmental disorders. The ASQ-3 met psychometric properties compared to the PRUNAPE, which is the gold standard for the targeted and systematic assessment of developmental milestones during health checkups in a rapid, simple and cost-effective manner, so it was considered useful to monitor child neurological development.


  • Evaluación de déficit de atención con hiperactividad: la escala SNAP IV adaptada a la Argentina

    by Nora Grañana, Alba Richaudeau, Carlos Robles Gorriti, Martín O'FLaherty, María Elena Scotti, Lucila Sixto, Ricardo Allegri, Natalio Fejerman

    Assess the usefulness of the SNAP-IV scale as an instrument for detecting attention deficit hyperactivity disorder (ADHD) in Argentine children aged 4 to 14 years. The SNAP-IV scale was adapted and administered to a group of 1 230 schoolchildren in the province of Buenos Aires, Argentina. The diagnosis was determined with the clinical control, based on the criteria of the Diagnostic and Statistical Manual of Mental Disorders, 4th edition. The sensitivity and specificity, as well as the cut-off scores for the SNAP-IV scale in the population studied, were determined. The score on the SNAP-IV scale with the best correlation between sensitivity and specificity was established in order to determine the true positive cases that in fact had a clinical diagnosis. The cut-off scores obtained were: 1.66 (15/27 points) for the attention deficit subscale and 1.77 (16/27 points) for hyperactivity/impulsivity in the population studied. The SNAP-IV scale for detection of ADHD is considered to be valid in the population studied as long as the cut-off scores are modified to obtain the best sensitivity/specificity ratio based on the cultural and socioeconomic features of the population.


    • 29 December 2010
      • Vol. 21  (91) , 245-9

    [Pubertal behavioral decompensation in patients with pervasive developmental disorders].

    by Nora Grañana, Paulo Taddeo, Pía Espoueys, Claudia Nazer

    To describe behavioral descompensation in adolescents with autistic spectrum disorders (ASD). We analyzed in a prospective study the stories of 11 children and adolescents with ASD, their demographic characteristics, initial symptoms of descompensation at pubertal or adolescence stages, interventions developed and evolution with them. We studied the clinical stories of eleven patients, 8 men and 3 women, who consulted with behavioral descompensation periods at a mean age of 13 years (range 10- 16 years). They presented with hyperactivity/agitation (6), injuries and aggression against others or themselves (6), irritability/ emotional labiality (6), inappropriate shouting (6), inflexibility/ rituals (4) and catatonia (2). Almost all patients had received psychiatric medication before descompensation, except patients with catatonia. Four of 11 presented two episodes and seven patients only one episode during a period of 2.7 years of follow-up (range 1- 6 years). Eight of 11 patients recovered with psychological and pharmacological (a medium of 2 drugs) interventions in a mean time of 4 months. Both patients with catatonia didn't recovered, and one more patient didn't improved with pharmacological treatment. Behavioral descompensations are very frequent complications in patients with autism at puberty or adolescence stages. Most of them recover with very close combined interventions and familial support.